SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-15-002838
Filing Date
2015-12-21
Accepted
2015-12-21 16:58:43
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422niv_12212015.htm SC 13G 200762
2 JOINT FILING AGREEMENT ex991to13g07422niv_12212015.htm EX-99.1 37891
  Complete submission text file 0000921895-15-002838.txt   240305
Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 720-945-7700
Nivalis Therapeutics, Inc. (Subject) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88896 | Film No.: 151300015
SIC: 2834 Pharmaceutical Preparations